- Home
- VTMX vs RXRX Comparison
VTMX vs RXRX Comparison
Compare VTMX & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTMX
- RXRX
- Stock Information
- Founded
- VTMX 1998
- RXRX 2013
- Country
- VTMX Mexico
- RXRX United States
- Employees
- VTMX N/A
- RXRX N/A
- Industry
- VTMX
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- VTMX
- RXRX Health Care
- Exchange
- VTMX Nasdaq
- RXRX Nasdaq
- Market Cap
- VTMX 2.3B
- RXRX 2.0B
- IPO Year
- VTMX 2023
- RXRX 2021
- Fundamental
- Price
- VTMX $27.54
- RXRX $5.26
- Analyst Decision
- VTMX Sell
- RXRX Buy
- Analyst Count
- VTMX 2
- RXRX 5
- Target Price
- VTMX $29.00
- RXRX $7.00
- AVG Volume (30 Days)
- VTMX 146.9K
- RXRX 32.1M
- Earning Date
- VTMX 07-24-2025
- RXRX 08-07-2025
- Dividend Yield
- VTMX 2.31%
- RXRX N/A
- EPS Growth
- VTMX N/A
- RXRX N/A
- EPS
- VTMX 0.13
- RXRX N/A
- Revenue
- VTMX $258,927,122.00
- RXRX $59,790,000.00
- Revenue This Year
- VTMX $17.35
- RXRX $23.51
- Revenue Next Year
- VTMX $11.82
- RXRX $53.87
- P/E Ratio
- VTMX $20.46
- RXRX N/A
- Revenue Growth
- VTMX 15.06
- RXRX 29.32
- 52 Week Low
- VTMX $21.30
- RXRX $3.79
- 52 Week High
- VTMX $32.84
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- VTMX 50.13
- RXRX 54.36
- Support Level
- VTMX $27.17
- RXRX $4.91
- Resistance Level
- VTMX $27.62
- RXRX $5.44
- Average True Range (ATR)
- VTMX 0.51
- RXRX 0.36
- MACD
- VTMX -0.01
- RXRX 0.01
- Stochastic Oscillator
- VTMX 54.38
- RXRX 66.51
About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)
Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.